Your browser doesn't support javascript.
loading
Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants.
Hu, Ye-Fan; Hu, Jing-Chu; Gong, Hua-Rui; Danchin, Antoine; Sun, Ren; Chu, Hin; Hung, Ivan Fan-Ngai; Yuen, Kwok Yung; To, Kelvin Kai-Wang; Zhang, Bao-Zhong; Yau, Thomas; Huang, Jian-Dong.
Affiliation
  • Hu YF; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Hu JC; Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong SAR, China.
  • Gong HR; Chinese Academy of Sciences Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Danchin A; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Sun R; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Chu H; Kodikos Labs, Paris, France.
  • Hung IF; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Yuen KY; Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong SARS, China.
  • To KK; Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong SAR, China.
  • Zhang BZ; Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong SARS, China.
  • Yau T; Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong SARS, China.
  • Huang JD; Chinese Academy of Sciences Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Front Immunol ; 13: 861050, 2022.
Article de En | MEDLINE | ID: mdl-35401572
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins contre la COVID-19 / SARS-CoV-2 / COVID-19 / Antigènes viraux Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Front Immunol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins contre la COVID-19 / SARS-CoV-2 / COVID-19 / Antigènes viraux Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Front Immunol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse